Rabbit Recombinant Monoclonal GluN2C antibody. Suitable for WB and reacts with Recombinant fragment - Mouse, Mouse, Rat samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IHC-Fr | IHC-P | WB | |
---|---|---|---|
Mouse | Not recommended | Not recommended | Tested |
Rat | Not recommended | Not recommended | Tested |
Recombinant fragment - Mouse | Not recommended | Not recommended | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Recombinant fragment - Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Recombinant fragment - Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Mouse | Dilution info 1/1000 | Notes - |
Species Mouse | Dilution info 1/1000 | Notes - |
Species Rat | Dilution info 1/1000 | Notes - |
Select an associated product type
Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:1377365). Participates in synaptic plasticity for learning and memory formation by contributing to the slow phase of excitatory postsynaptic current and long-term synaptic potentiation (PubMed:8987814). Channel activation requires binding of the neurotransmitter L-glutamate to the GluN2 subunit, glycine or D-serine binding to the GluN1 subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) (PubMed:1377365, PubMed:7790891). NMDARs mediate simultaneously the potasium efflux and the influx of calcium and sodium (By similarity). Each GluN2 subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, Ca2(+) permeability, and binding to allosteric modulators (PubMed:1377365). Plays a role in regulating the balance between excitatory and inhibitory activity of pyramidal neurons in the prefrontal cortex (PubMed:27922130).
GluN2C, Glutamate [NMDA] receptor subunit epsilon-3, N-methyl D-aspartate receptor subtype 2C, NMDAR2C, NR2C, Grin2c
Rabbit Recombinant Monoclonal GluN2C antibody. Suitable for WB and reacts with Recombinant fragment - Mouse, Mouse, Rat samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
GluN2C also known as NR2C is a subunit of the NMDA (N-methyl-D-aspartate) receptor an important ion channel in the central nervous system. This protein with a molecular weight of approximately 140 kDa is mainly expressed in the cerebellum and certain thalamic regions of the brain. GluN2C forms part of the ligand-gated ion channels which are important for synaptic transmission and plasticity. By co-assembling with other subunits of NMDA receptors GluN2C plays a vital role in modulating the receptor's response to neurotransmitters like glutamate and glycine.
NMDA receptors which include the GluN2C subunit perform important functions in calcium ion influx across the cell membrane when activated. This calcium signaling is important for processes such as neuronal development synaptic plasticity and cognitive functions like learning and memory. The NMDA receptor operates as a heterotetrameric complex typically assembled from two GluN1 and two GluN2 (or GluN3) subunits with GluN2C representing one of several variants of the GluN2 subunit.
GluN2C plays a role in the glutamatergic signaling pathway which is critical for excitatory neurotransmission in the brain. This pathway includes interactions with proteins such as PSD-95 and CaMKII which are important for synaptic strength and plasticity. Another key pathway is the calcium signaling pathway where GluN2C contributes to calcium-mediated cellular responses influencing neuronal excitability and survival.
GluN2C has associations with neurological conditions like schizophrenia and cerebellar ataxia. Alterations in NMDA receptor function including changes involving the GluN2C subunit can lead to dysregulated synaptic signaling observed in these disorders. In schizophrenia the GluN2C-containing NMDA receptors may interact with synaptic proteins like PSD-95 potentially affecting synaptic architecture and neurotransmitter dynamics. In cerebellar ataxia disruptions in GluN2C expression or function could impair motor coordination emphasizing the importance of proper NMDA receptor function for neurological health.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking/Dilution buffer: 5% NFDM/TBST.
Exposure time: Lane 1,2,3 and 4: 1 minute; Lane 5: 15 seconds.
All lanes: Western blot - Anti-GluN2C antibody [EPR19046] (ab192831) at 1/1000 dilution
Lane 1: Mouse cerebellum lysate at 20 µg
Lane 2: Mouse heart lysate at 20 µg
Lane 3: C6 (Rat glial tumor cell line) whole cell lysate at 20 µg
Lane 4: Rat liver lysate at 20 µg
Lane 5: Rat cerebellum lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 134 kDa
Observed band size: 135 kDa
Blocking/Dilution buffer: 5% NFDM/TBST.
Exposure time: Lane 1: 1 second; Lane 2: 3 minutes.
Mouse GluN2C fragment recombinant protein contains aa300-499 with a His-Tag®. NMDAR2D fragment recombinant protein contains aa328-526 with a His-Tag®. These two recombinant proteins were made in-house. NMDAR2A and NMDAR2B were not tested, as bands of their size (180 kD) were not detected in tissue lysates.
All lanes: Western blot - Anti-GluN2C antibody [EPR19046] (ab192831) at 1/1000 dilution
Lane 1: Mouse GluN2C fragment recombinant protein at 0.01 µg
Lane 2: Mouse NMDAR2D fragment recombinant protein at 0.01 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 134 kDa, 22 kDa
Observed band size: 22 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com